| Bioactivity | CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid |
| Name | CJ-13,610 |
| CAS | 179420-17-8 |
| Formula | C22H23N3O2S |
| Molar Mass | 393.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fischer L, et al. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610. Br J Pharmacol. 2004;142(5):861-868. |
CJ-13,610
CAS: 179420-17-8 F: C22H23N3O2S W: 393.50
CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimul
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.